Invesco Ltd. Surface Oncology, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $15,245 - $33,818	-10,736 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.65 - $5.08 $341 - $655	129 Added 1.22%	10,736 $31,000
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $51,888 - $86,663	-10,970 Reduced 50.84%	10,607 $51,000
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $20,588 - $31,840	3,990 Added 22.69%	21,577 $163,000
Q2 2021 Aug 17, 2021	BUY	$6.45 - $9.09 $113,436 - $159,865	17,587 New	17,587 $131,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.